Upload File

powerpoint presentation · box i criteria for the diagnosis ofhomozygous familial...

  • Home
  • Documents
  • PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
20
1

Upload: others

Post on 19-Jan-2020

4 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

1

Page 2: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

2

•

•

•

•

Page 3: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 4: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

Page 5: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

•

•

•

Page 6: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

Page 7: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 8: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 9: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

-

-

-

-

-

Page 10: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

••••

Page 11: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 12: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•••

•

•

Page 13: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

Page 14: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 15: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

•

Page 16: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

Page 17: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

•

Page 18: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI
Page 19: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

•

•

•

•

Page 20: PowerPoint Presentation · Box I Criteria for the diagnosis ofhomozygous familial hypercholesterolaemia Genetic confirmation of two mutantallelesatthe LDLR,APOB, PCSK9, or I-DI-RAPI

Inherited heart conditions Familial hypercholesterolaemia

Bempedoic acid for treating primary hypercholesterolaemia

Personalized medicine in Familial Hypercholesterolaemia

Familial Hypercholesterolaemia in a Bulgarian Population ...familial hypercholesterolaemia (FH) are at very high risk of cardiovascular events, but rates of FH detection are very low

Familial Hypercholesterolaemia: Finding FH and Primary ... Gingell - FH and Primary... · Familial Hypercholesterolaemia: Finding FH and Primary Prevention Rob Gingell FH Specialist

LIFE WITH FAMILIAL HYPERCHOLESTEROLAEMIA

Assessment report · lipoprotein (a) [Lp(a)] in patients with homozygous familial hypercholesterolaemia (HoFH) and in patients with severe heterozygous familial hypercholesterolaemia

Human LDL Receptor / LDLR ELISA Kit · 2020. 2. 4. · LDL Receptor, also known as LDLR, is a mosaic protein which belongs to the Low density lipoprotein receptor gene family. The

The Proprotein Convertase Subtilisin/Kexin Type 9-resistant … · 2017. 2. 6. · the latter representing a new class 8 LDLR mutation (Table 1), and we show that the LDLR-G592E does

PCSK9 Regulates LDLR Turnover Through Increased Intracellular Degradation

The balance between apoB and apoA-I, i.e. the apoB/apoA-I ratio, indicates cardiovascular risk; the higher the ratio, the higher is the risk G. Walldius

Humanapolipoprotein B (apoB) mRNA: Identification of mRNAs ... · apoB-Gln synthetic probes as well as by cDNA sequencing revealed that liver apoB mRNAalso contains both the apoB-100mRNAandtheapoB-48mRNAcontainingthestopcodon

The Economic Burden of Hypercholesterolaemia

Rare and common variants of APOB and PCSK9 in Korean ... · RESEARCH ARTICLE Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholest

Familial hypercholesterolaemia: identification and managementpathlabs.rlbuht.nhs.uk/familial-hypercholesterolaemia-identification... · defect known as familial hypercholesterolaemia

Chapter 4 Platelet activation by the apoB/E receptor ... 4 Platelet activation by the apoB/E receptor-binding domain of LDL Ingrid A.M. Relou 1, 3, Gertie Gorter 1 ... USA) and SK&F

Familial hypercholesterolaemia: A global call to arms · Familial hypercholesterolaemia: A global call to arms Antonio J. Vallejo-Vaz a, Sreenivasa Rao Kondapally Seshasai b, Della

Familial Hypercholesterolaemia...Familial Hypercholesterolaemia – support for the implementation of a systems approach to its detection and management 8 Key messages Facts and figures

PRESENTED BY DTN. SOWOOLU-COATES REGISTERED DIETITIAN REGISTERED NUTRITIONIST MSC.,BSC.[NUT$DIET] HYPERCHOLESTEROLAEMIA

Finding undiagnosed Familial Hypercholesterolaemia (FH ......Finding undiagnosed Familial Hypercholesterolaemia (FH) patients in your practice December 2012 One person in every five

Familial Hypercholesterolaemiapathology.imperial.nhs.uk/uploads/images/Familial... · Genetics of Familial Hypercholesterolemia Major Defect • Low density lipoprotein receptor (LDLR

Bristol Genetics Laboratory Familial Hypercholesterolaemia: LIPOchip ® experience Laura Yarram Bristol Genetics Laboratory

Effects of Hypercholesterolaemia in the Retina · 2012-09-19 · Effects of Hypercholesterolaemia in the Retina 3 choroid and the RPE. The basement membrane of the choriocapillaris

Intervention to improve LDL receptor function Emerging Therapies › sites › default › files › 9._cuchel... · 2017-05-26 · ↓Cholesterol ↑ LDLR ↑ PCSK9 ... • Evinacumab

The elevation of apoB in hypercholesterolemic patients is · PDF fileThe elevation of apoB in hypercholesterolemic patients is primarily attributed to the relative increase of the

Familial Hypercholesterolaemia - My Family History

InheriGen Plus Disease List - GenPath Diagnostics · 2019. 4. 24. · Familial Dysautonomia Familial Hypercholesterolemia, Homozygous, LDLR-Associated Familial Hypercholesterolemia,

Inclisiran for treating primary hypercholesterolaemia or

Thinkings on Lipids: Genetics, apoB, HDL, and PCSK9 inhibition/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Meetings/2016...Lp(a) Lipoproteins and CAD. ApoB-lipoproteins are biomarkers

Familial Hypercholesterolaemia - PCSK9 Forum · Familial Hypercholesterolaemia ... Unilever, Danone , Aegerion ... DNA-based evidence of an LDL-r, apoB-100, or a PCSK9 mutation

Application of next generation sequencing to aid in effective ......2019/04/12  · mutations in the three genes LDLR, APOB and PCSK9. Aim To set up Next Generation Sequencing (NGS)

Dr Jaimini Ceglas - Familial Hypercholesterolaemia GP Day

Familial hypercholesterolaemia: identification and management

AUSTRALIAN PRODUCT INFORMATION ZOCOR (simvastatin) … · 2020. 7. 12. · hypercholesterolaemia (HeFH). Prior to initiating therapy with ZOCOR, secondary causes of hypercholesterolaemia

Primate-Specific Evolution of an LDLR Enhancer/67531/metadc880954/m2/1/high... · Primate-Specific Evolution of an LDLR Enhancer Qian-fei Wang1,3*, Shyam Prabhakar1,3*, Qianben Wang2,